The effect of magnesium deficiency on volatile anaesthetic requirement in the rat: The role of central noradrenergic neuronal activity

Magnesium Research

Volumn 14, Issue 3, 2001, Pages 195-201

  Thomas, Mark L ^a   Crawford, Mark W ^a   Shams, Merajuddin ^a   Gow, Robert ^a   Carmichael, Frederick J ^b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

3,4 Dihydroxyphenylethyleneglycol; Anaesthetics; Magnesium; Norepinephrine; Potency

Indexed keywords

3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; DRUG DERIVATIVE; ETHER DERIVATIVE; HALOTHANE; INHALATION ANESTHETIC AGENT; NORADRENALIN; SEVOFLURANE;

ANIMAL; ARTICLE; BRAIN; CHEMISTRY; DIET; MAGNESIUM DEFICIENCY; MALE; METABOLISM; NERVE CELL; RAT; SPRAGUE DAWLEY RAT; TIME;

ANESTHETICS, INHALATION; ANIMALS; BRAIN; DIET; HALOTHANE; MAGNESIUM DEFICIENCY; MALE; METHOXYHYDROXYPHENYLGLYCOL; METHYL ETHERS; NEURONS; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0035464072     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Rose, K., Christine, C.W. & Choi, D.W. (1990): Magnesium removal induces paroxysmal neuronal firing and NMDA receptor-mediated neuronal degeneration in cortical cultures. Neurosci. Lett. 115, 313-317.
2. Meltzer, S.J. & Auer, J. (1905): Physiological and pharmacological studies of magnesium salts. I. General anaesthesia by subcutaneous injection. Am. J. Physiol. 14, 361-388.
3. Thompson SW, Moscicki JC, DiFazio CA (1988): The anesthetic contribution of magnesium sul- phate and ritodrine hydrochloride in rats. Anesth. Analg. 67, 31-34.
4. Louie, G.I., Prokocimer, P.G., Nicholls, E.A. & Maze, M. (1986): Aminophylline shortens thiopental sleep-time and enhances noradrenergic neurotransmission in rats. Brain Res. 383, 377-381.
5. Smythe, G.A., Bradshaw, J.E. & Vining, R.F. (1983): Hypothalamic monoamine control of stress-Induced adrenocorticotropin release in the rat. Endocrinology 113, 1062-1071.
6. White, P.F., Johnston, R.R. & Eger, E.I. (1974): Determination of anesthetic requirement in rats. Anesthesiology 40, 52-57.
7. Musso, N.R., Vergassola, C., Pende, A. & Lotti, G. (1989): Reversed-phase HPLC separation of plasma norpinephrine, epinephrine, and dopamine, with three-electrode coulometric detection. Clin. Chem. 35, 1975-1977.
8. Chutkow, J.G. (1990): Magnesium and the central (intradural) nervous system: Metabolism, neurophysiological functions, and clinical disorders, metal ions in biological systems, vol. 26: Compendium on magnesium arid its role in biology, nutrition, and physiology, ed. H. Sigel & A. Sigel. New York: Dekker, pp. 417-440.
9. Chutkow, J.G. (1990): Magnesium and the peripheral (extradural) nervous system: Metabolism, neurophysiological functions, and clinical disorders, metal ions in biological systems, vol. 26: Compendium on magnesium and its role in biology, nutrition, and physiology, ed. H. Sigel & A. Sigel. New York: Dekker, pp. 441-462.
10. Durlach, J., Bac, P., Bara, M. & Guiet-Bara, A. (2000): Pathophysiology of symptomatic and latent forms of central nervous hyperexcitability due to magnesium deficiency: a current general scheme. Magnes. Res. 13, 293-302.
11. Miller, R., Way, W. & Eger, E. I. II (1964): The effects of alpha-methyldopa, reserpine, guanethidine and iproniazid on minimum anesthetic requirement (MAC). Anesthesiology 25, 302-306.
12. Mueller, R.A., Smith, R.D., Spruill, W.A. & Breese, G.R. (1975): Central monoaminergic neuronal effects on minimum alveolar concentration (MAC) of halothane and cyclopropane in rats. Anesthesiology 42, 142-153.
13. Roizen, M.F., White, P.F., Eger, E.I. & Brownstein, M. (1978): Effects of ablation of serotonin or norepinephrine brainstem on halothane and cyclopropane MAC in rats. Anesthesiology 49, 252-255.
14. Segal, I.S., Vickery, R.G., Walton, J., Doze, V.A. & Maze, M. (1988): Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha2 adrenergic receptor. Anesthesiology 69, 818-823.
15. Glossman, H., Hornung, R. & Presek, P. (1980): The use of ligand-binding for the characterization of alpha-adrenoceptors. J. Cardiovas. Pharmacol. 2, 303-324.
16. Smythe, G.A., Duncan, M.W., Bradshaw, J.E. & Cai, W.Y. (1982): Serotoninergic control of growth hormone secretion: hypothalamic dopamine, norepinephrine and serotonin levels and metabolism in three hyposomatotropic rat models and in normal rats. Endocrinology 110, 376-383.
17. Heffner, T.G., Hartman, J.A. & Seiden L.S. (1980): Feeding increases dopamine metabolism in the rat brain. Science 208, 1168-1170.
18. Tozer, T.N., Neff, N.H. & Brodie, B.B. (1966): Application of steady state kinetics of the synthesis rate and turnover time of seotonin in the brain of normal and reserpine-treated rats. J. Pharmacol. Exp. Ther. 153, 177-182.
19. Aymard, N., Leyris, A., Monier, C., Frances, H., Boulu, R.G. & Henrotte, J-G (1994): Brain catecholamines, serotonin and their metabolites in mice selected for low (MGL) and high (MGH) blood magnesium levels. Magnes. Rese. 8, 5-9.
20. Stone, T.W., Connick, J.H. & Bartrup, J.T. (1990): NMDA-receptor-independent effects of low magnesium: involvement of adenosine. Brain Res. 508, 333-336
21. Fredholm, B.B., Hedquist, P. (1980): Modulation of neurotransmission by purine nucleotides and nucleosides. Biochem. Pharmacol. 20, 1635-1643.
22. Fredholm, B.B., Jonzon, B. & Lindgren, E. (1984): Changes in noradrenaline release and in beta receptor number in rat hippocampus following long-term treatment with theophylline or L-phenylisopropyladenosine. Acta Physiol. Scand. 122, 55-59.
23. Fink, K., Bonisch, H. & Gotherd, M. (1990): Presynaptic NMDA receptors stimulate noradrenaline release in the cerebral cortex. Eur. J. Pharmacol. 185, 115-117.
24. Pittaluga, A. & Raiteri, M. (1990): Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals in the hippocampus. Eur. J. Pharmacol. 191, 231-234.
25. Rayssiguier, Y., Mazur, A., Gueux, E. et al. (1996): Magnesium deficiency affects lipid metabolism and atherosclerosis process by a mechanism inflammation and oxidative stress. Current research in magnesium, ed. M.H. Halpern & J. Durlach. Paris: John Libbey, pp. 251-255.
26. Weglicki, W.B. & Philips, T.M. (1992): Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am. J. Physiol. 263, R734-737.
27. Dubray, C., Alloui, A., Bardin, L., Rock, E., Mazur, A., Rayssiguier, Y., Eschalier, A. & Lavarenne, J. (1997): Magnesium deficiency induces an hyperalgesia reversed by the NMDA receptor antagonist MK801. NeuroReport 8, 1383-1386.
28. Xiao, W. & Bennett, G.J. (1994): Magnesium suppresses neuropathic pain responses in rats via a spinal site of action. Brain Res. 666, 168-172
29. Douglas, B.C. & Dagirmanjian, R. (1975): The effects of magnesium deficiency on ketamine sleeping times in the rat. Br. J. Anaesth. 47, 336-340.
30. Orser, B., Smith, D., Henderson, S. & Gelb, A. (1997): Magnesium deficiency increases ketamine sensitivity in rats. Can. J. Anaesth. 44, 883-890.
31. MacDonald, J.F., Bartlett, M.C., Mody, I., Pahapill, P., Reynolds, J.N., Salter, M.W., Schneiderman, J.H. & Pennefatheer, P.S. (1991): Action of ketamine, phencyclidine, and MK-801 on NMDA receptor currents in cultured mouse hippocampal neurones. J. Physiol. 432, 483-508.
32. Poenaru, S., Manicom, R., Rouhani, S., Aymard, P., Bajenaru, O., Rayssiguier, Y., Emmanouillidis, E., Gueux, E., Nkanga, N., Durlach, J. & Dall'ava, J. (1997): Stability of brain content of magnesium in experimental hypomagnesemia. Brain Res. 769:329-32.
33. Buch, D.R., Mahoney, A.W. & Hendricks, D.G. (1979): Effects of cerebral intraventricular magnesium injections and a low magnesium diet on non-specific excitability level, audiogenic seizure susceptibility and serotonin. Pharmocol. Biochem. Behav. 10, 487-491.
34. Kantak, K.M. (1988): Magnesium deficiency alters aggressive behavior and catecholamine function. Behav. Neurosci. 102, 304-311.
35. Thurmond, J.B., Lasley, S.M., Conkin, A.L. & Brown, S.W. (1977): Effects of dietary tyrosine, phenylalanine and tryptophan on aggression in mice. Pharmacol. Biochem. Behav. 12, 667-674.
36. Miczek, K.A. (1977): Effects of 1-dopa, d-amphetamine and cocaine on intruder-evoked aggression in rats and mice. Prog. Neuropsychopharm. 1, 271-277.